SCHEMBL9770613

SCHEMBL9770613

Cc1csc2nc3cccc(C(F)(F)F)c3c(=O)n12

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.61
HSD17B10 Q99714 4/20 0.61
ALDH1A1 P00352 4/20 0.61
HPGD P15428 2/20 0.61
SMN1; SMN2 Q16637 4/20 0.45
RCE1 Q9Y256 1/20 0.45
GLA P06280 1/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
XPO1 O14980 1/20 0.40
HRH3 Q9Y5N1 2/20 0.39
KCNH2 Q12809 1/20 0.39
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10668697 0.83 ALDH1A1 (0.62) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL9532203 0.82 KDM4E (0.65) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
Bromide SCHEMBL11085283 0.82 ALDH1A1 (0.60) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL9535003 0.80 ALDH1A1 (0.62) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL9533630 0.80 KDM4E (0.62) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL9532680 0.78 KDM4E (0.63) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL9534712 0.78 KDM4E (0.59) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL10978164 0.76 KDM4E (1.00) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL9538352 0.75 KDM4E (0.55) KDM4EHSD17B10ALDH1A1HPGDSMN1; SMN2
SCHEMBL10696638 0.74 CYP1A2 (0.40) KDM4EHSD17B10ALDH1A1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5030727-A Reacting an anthronilide derivative with a thiazole derivative or a fluorozuinazolone with a neucleophile BASF AKTIENGESELLSCHAFT (DE) 1991-07-09 US disclosed
EP-0263523-A2 Process for the preparation of thiazolo [2,3-b] quinazolones BASF Aktiengesellschaft (DE) 1988-04-13 EP disclosed